We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
TransMedics Group, Inc.
Health Care · Health Care Equipment & Supplies
STRUCTURAL EDGE
• Only FDA-cleared normothermic perfusion system across all three solid-organ modalities (heart, lung, liver); no direct platform competitor has achieved that breadth.
• National OCS Program converts a device sale into a recurring per-case service fee (~$40K-$60K/case) - transforming episodic capital equipment revenue into a volume-driven annuity tied to US transplant throughput.
• Transplant volume is supply-constrained, not demand-constrained; OCS expands the usable donor pool by resuscitating marginal organs that would be discarded under cold storage, creating net-new addressable volume rather than share-taking.
• Proprietary flight network and 24/7 perfusionist staffing create a logistics moat that is operationally difficult to replicate quickly.
• International expansion (OCS Heart/Lung EU) provides a second growth vector uncorrelated to US reimbursement cycles.
BULL CASE
• TAM expansion: ~40,000 annual US solid-organ transplants; penetration still sub-30% in addressable categories.
• NOP gross margins structurally improve as flight utilization rises on a largely fixed cost base.
• CMS reimbursement codes for machine perfusion, once formalized, de-risk hospital budget friction.
• Pipeline: OCS Kidney in development - kidneys are the highest-volume transplant category (~25,000/yr US).
• First-mover regulatory moat: FDA 510(k)/PMA pathway for a competing system takes 5-7 years minimum.
BEAR CASE
• Revenue concentration: NOP economics are lumpy and dependent on case scheduling; a logistics disruption (FAA, weather, staffing) can materially shift quarterly results.
Each weekday: the scan's ENTER setups with entry, stop and target, every new ticker teardown, and the bubble shifts that move names like this one. Free. Education, not advice.
No spam. One email per day max. Pro adds Telegram trade alerts and higher AI-assistant limits.
• Gross margins are structurally lower than pure-device peers due to high per-case labor and flight costs; path to 50%+ GM requires scale that is not yet guaranteed.
• Execution risk: scaling a 24/7 national logistics operation is operationally intensive - any adverse event (organ loss, flight incident) carries reputational and legal tail.
• Reimbursement uncertainty: NOP billing codes are still evolving; adverse CMS rulings would directly compress revenue per case.
Auto-computed retracement of the trailing 52w low-high leg. Recomputed on each refresh; not a curated level.
Auto-computed retracement of the trailing 52w low-high leg. Recomputed on each refresh; not a curated level.
Auto-computed retracement of the trailing 52w low-high leg. Recomputed on each refresh; not a curated level.
Auto-computed retracement of the trailing 52w low-high leg. Recomputed on each refresh; not a curated level.